Shoyo Shibata

Factors That Affect the Acquisition of Reward Premiums for Promotion of Innovative Drug Discovery in Japan

Shoyo Shibata, Ryotaro Uemura, Takeshi Suzuki · Therapeutic Innovation & Regulatory Science · 2015 · 25 citations

Management, Innovation Management, Pharmaceutical Policy +10

Impact of Premium Rewards for the Promotion of Innovative Drug Discovery on the Japanese Pharmaceutical Market: An Analysis by Therapeutic Area

Shoyo Shibata, Ryotaro Uemura, Takeshi Suzuki · Therapeutic Innovation & Regulatory Science · 2015 · 23 citations

Pharmacy, Pharmaceutical Policy, Drug Discovery +13

Evaluating the Effectiveness of Repricing for Market Expansion in the Japanese Drug Pricing System

Shoyo Shibata, Ryotaro Uemura, Takeshi Suzuki · Therapeutic Innovation & Regulatory Science · 2016 · 18 citations

Management, Marketing, Marketing Management +13

Comparative Analysis Between the Top-Selling Drugs in the Japanese Pharmaceutical Market and Those in the United States, the United Kingdom, France, and Germany

Shoyo Shibata, Ryotaro Uemura, Takeshi Suzuki · Therapeutic Innovation & Regulatory Science · 2015 · 16 citations

Social Sciences, Pharmacology, Pharmaceutical Regulation +9

Phase I study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumors

Noboru Yamamoto, Takafumi Koyama, Jun Sato et al. · Cancer Chemotherapy and Pharmacology · 2024 · 16 citations · Full text

Medicine, Oncology, Pharmacology +17